{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:17:36Z","timestamp":1791393456937,"version":"4.3.3"},"reference-count":85,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.jhep.2016.09.012","type":"journal-article","created":{"date-parts":[[2016,9,24]],"date-time":"2016-09-24T23:50:06Z","timestamp":1474761006000},"page":"412-423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":136,"title":["Personalized treatment of patients with very early hepatocellular carcinoma"],"prefix":"10.1016","volume":"66","author":[{"given":"Alessandro","family":"Vitale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Peck-Radosavljevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo G.","family":"Giannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Vibert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Sieghart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Van Poucke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"Pawlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2016.09.012_b0005","unstructured":"GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Available from: http:\/\/globocan.iarc.fr, accessed on 13\/12\/2013]."},{"key":"10.1016\/j.jhep.2016.09.012_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.soc.2014.09.001","article-title":"Epidemiology of hepatocellular carcinoma","volume":"24","author":"Lafaro","year":"2015","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.jhep.2016.09.012_b0015","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","article-title":"Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver","volume":"35","author":"Bruix","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.09.012_b0020","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.20933","article-title":"Practice guidelines committee, American association for the study of liver diseases. Management of hepatocellular carcinoma","volume":"42","author":"Bruix","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.09.012_b0025","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.09.012_b0030","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1053\/j.gastro.2015.12.041","article-title":"Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma","volume":"150","author":"Bruix","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.09.012_b0035","doi-asserted-by":"crossref","DOI":"10.1136\/ebmed-2016-110401","article-title":"New evidence pyramid","author":"Murad","year":"2016","journal-title":"Evid Based Med"},{"key":"10.1016\/j.jhep.2016.09.012_b0040","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.2196\/jmir.5549","article-title":"Are randomized controlled trials the (G)old Standard? From clinical intelligence to prescriptive analytics","volume":"18","author":"Van Poucke","year":"2016","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.jhep.2016.09.012_b0045","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nrgastro.2014.18","article-title":"Big data in gastroenterology research","volume":"11","author":"Genta","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2016.09.012_b0050","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/01.sla.0000201480.65519.b8","article-title":"A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma","volume":"243","author":"Chen","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhep.2016.09.012_b0055","first-page":"801","article-title":"Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial","volume":"86","author":"Lu","year":"2006","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.jhep.2016.09.012_b0060","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/SLA.0b013e3181efc656","article-title":"A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria","volume":"252","author":"Huang","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhep.2016.09.012_b0065","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jhep.2012.05.007","article-title":"A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma","volume":"57","author":"Feng","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.09.012_b0070","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/jgh.12441","article-title":"Comparison of long-term effectiveness and complications of radiofrequency ablation with hepatectomy for small hepatocellular carcinoma","volume":"29","author":"Fang","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2016.09.012_b0075","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/bjs.10061","article-title":"Randomized clinical trial of chemoembolization plus radiofrequency ablation versus partial hepatectomy for hepatocellular carcinoma within the Milan criteria","volume":"103","author":"Liu","year":"2016","journal-title":"Br J Surg"},{"key":"10.1016\/j.jhep.2016.09.012_b0080","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/MCG.0000000000000008","article-title":"Radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma: a meta-analysis of randomized controlled trials","volume":"48","author":"Qi","year":"2014","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2016.09.012_b0085","doi-asserted-by":"crossref","first-page":"e84484","DOI":"10.1371\/journal.pone.0084484","article-title":"Radiofrequency ablation versus hepatic resection for small hepatocellular carcinomas: a meta-analysis of randomized and nonrandomized controlled trials","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2016.09.012_b0090","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1148\/radiol.11110817","article-title":"Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study","volume":"262","author":"Peng","year":"2012","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2016.09.012_b0095","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jhep.2013.03.009","article-title":"Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma \u2a7d3cm. Results of a multicenter Italian survey","volume":"59","author":"Pompili","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.09.012_b0100","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/MEG.0000000000000012","article-title":"Liver resection and radiofrequency ablation of very early hepatocellular carcinoma cases (single nodule <2cm): a single-center study","volume":"26","author":"Zhou","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2016.09.012_b0105","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/SLA.0000000000001178","article-title":"Surgical resection versus radiofrequency ablation for single hepatocellular carcinoma \u2a7d2cm in a propensity score model","volume":"263","author":"Liu","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhep.2016.09.012_b0110","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/bjs.9960","article-title":"Radiofrequency ablation as an alternative to hepatic resection for single small hepatocellular carcinomas","volume":"103","author":"Kim","year":"2016","journal-title":"Br J Surg"},{"key":"10.1016\/j.jhep.2016.09.012_b0115","article-title":"Laparoscopic hepatectomy versus radiofrequency ablation for minimally invasive treatment of single, small hepatocellular carcinomas","author":"Song","year":"2015","journal-title":"Surg Endosc"},{"key":"10.1016\/j.jhep.2016.09.012_b0120","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MCG.0000000000000133","article-title":"Radiofrequency ablation is better than surgical resection in patients with hepatocellular carcinoma within the Milan criteria and preserved liver function: a retrospective study using propensity score analyses","volume":"49","author":"Lee","year":"2015","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2016.09.012_b0125","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jamcollsurg.2014.12.030","article-title":"Surgical treatment of hepatocellular carcinoma in North America: can hepatic resection still be justified?","volume":"220","author":"Chapman","year":"2015","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jhep.2016.09.012_b0130","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/TP.0b013e3182a89383","article-title":"Liver transplantation versus liver resection in the treatment of hepatocellular carcinoma: a meta-analysis of observational studies","volume":"97","author":"Zheng","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2016.09.012_b0135","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/ctr.12273","article-title":"Hepatocellular carcinoma in Child\u2019s A cirrhosis: a retrospective analysis of matched pairs following liver transplantation vs. liver resection according to the intention-to-treat principle","volume":"28","author":"Foltys","year":"2014","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jhep.2016.09.012_b0140","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/SLA.0b013e318273bad0","article-title":"Resection or transplantation for early hepatocellular carcinoma in a cirrhotic liver: does size define the best oncological strategy?","volume":"256","author":"Adam","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhep.2016.09.012_b0145","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/SLA.0000000000001442","article-title":"Salvage versus primary liver transplantation for early hepatocellular carcinoma: do both strategies yield similar outcomes?","volume":"264","author":"Bhangui","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhep.2016.09.012_b0150","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1245\/s10434-012-2655-1","article-title":"Single HCC in cirrhotic patients: liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basis","volume":"20","author":"Sapisochin","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jhep.2016.09.012_b0155","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/hep.23466","article-title":"Hepatic resection versus radiofrequency ablation for very early stage hepatocellular carcinoma: a Markov model analysis","volume":"51","author":"Cho","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.09.012_b0160","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jhep.2013.04.009","article-title":"Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma","volume":"59","author":"Cucchetti","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.09.012_b0165","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/hep.24680","article-title":"Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis","volume":"55","author":"Fuks","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.09.012_b0170","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/hep.28339","article-title":"Prospective validation of \u201cab initio\u201d liver transplantation in hepatocellular carcinoma upon detection of risk factors for recurrence after resection","volume":"63","author":"Ferrer-F\u00e0brega","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.09.012_b0175","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/hep.27431","article-title":"Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis","volume":"61","author":"Berzigotti","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.09.012_b0180","series-title":"Institute of medicine initial national priorities for comparative effectiveness research","year":"2009"},{"key":"10.1016\/j.jhep.2016.09.012_b0185","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1097\/MLR.0b013e3181da3709","article-title":"Defining comparative effectiveness research: the importance of getting it right","volume":"48","author":"Sox","year":"2010","journal-title":"Med Care"},{"key":"10.1016\/j.jhep.2016.09.012_b0190","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/hep.23648","article-title":"Partial hepatectomy versus radiofrequency ablation for hepatocellular carcinoma: confirming the trial that will never be, and some comments on the indications for liver resection","volume":"51","author":"Majno","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.09.012_b0195","doi-asserted-by":"crossref","first-page":"S144","DOI":"10.1016\/j.jhep.2015.02.007","article-title":"Liver cancer: approaching a personalized care","volume":"62","author":"Bruix","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.09.012_b0200","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/hep.27745","article-title":"The role of hepatic resection in the treatment of hepatocellular cancer","volume":"62","author":"Roayaie","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.09.012_b0205","doi-asserted-by":"crossref","DOI":"10.1111\/liv.13107","article-title":"The recommended treatment algorithms of the BCLC and HKLC staging systems: does following these always improve survival rates for HCC patients?","author":"Kim","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2016.09.012_b0210","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1053\/j.gastro.2015.05.025","article-title":"Comparison of liver transplant-related survival benefit in patients with versus without hepatocellular carcinoma in the United States","volume":"149","author":"Berry","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.09.012_b0215","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1053\/j.gastro.2015.12.002","article-title":"Estimation of liver transplant related survival benefit: the devil is in the details","volume":"150","author":"Vitale","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.09.012_b0220","doi-asserted-by":"crossref","first-page":"9183","DOI":"10.3748\/wjg.v19.i48.9183","article-title":"Transplant benefit for patients with hepatocellular carcinoma","volume":"19","author":"Vitale","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2016.09.012_b0225","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/lt.24214","article-title":"Utility-based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha-fetoprotein model as a survival predictor","volume":"21","author":"Vitale","year":"2015","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2016.09.012_b0230","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/S1470-2045(11)70144-9","article-title":"Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study","volume":"12","author":"Vitale","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jhep.2016.09.012_b0235","first-page":"212A","article-title":"Intention-to-treat outcome of T1 hepatocellular carcinoma using the approach of \u201cwait and not ablate\u201d until meeting T2 criteria for liver transplant listing","volume":"58","author":"Mehta","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.09.012_b0240","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1600-6143.2011.03853.x","article-title":"Are patients with Child\u2019s A cirrhosis and hepatocellular carcinoma appropriate candidates for liver transplantation?","volume":"12","author":"Berry","year":"2012","journal-title":"Am J Transpl"},{"key":"10.1016\/j.jhep.2016.09.012_b0245","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jhep.2013.10.010","article-title":"A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list","volume":"60","author":"Vitale","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.09.012_b0250","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.jhep.2014.01.022","article-title":"Is resectable hepatocellular carcinoma a contraindication to liver transplantation? A novel decision model based on \u201cnumber of patients needed to transplant\u201d as measure of transplant benefit","volume":"60","author":"Vitale","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.09.012_b0255","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1245\/s10434-014-4099-2","article-title":"The survival benefit of liver transplantation versus resection for hepatocellular carcinoma: impact of MELD score","volume":"22","author":"Vitale","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jhep.2016.09.012_b0260","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jhep.2011.03.026","article-title":"Survival after radiofrequency ablation and salvage transplantation in patients with hepatocellular carcinoma and Child-Pugh A cirrhosis","volume":"56","author":"N\u2019Kontchou","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.09.012_b0265","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/hep.27135","article-title":"Cost-effectiveness analysis of liver resection versus transplantation for early hepatocellular carcinoma within the Milan criteria","volume":"61","author":"Lim","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.09.012_b0270","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1007\/s00268-015-2987-7","article-title":"The relative net health benefit of liver resection, ablation, and transplantation for early hepatocellular carcinoma","volume":"39","author":"Spolverato","year":"2015","journal-title":"World J Surg"},{"key":"10.1016\/j.jhep.2016.09.012_b0275","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.surg.2010.10.001","article-title":"Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS)","volume":"149","author":"Rahbari","year":"2011","journal-title":"Surgery"},{"key":"10.1016\/j.jhep.2016.09.012_b0280","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s11605-013-2423-y","article-title":"Assessment of ISGLS definition of posthepatectomy liver failure and its effect on outcome in patients with hepatocellular carcinoma","volume":"18","author":"Fukushima","year":"2014","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.jhep.2016.09.012_b0285","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/bjs.9815","article-title":"Anatomical versus non-anatomical resection for hepatocellular carcinoma","volume":"102","author":"Marubashi","year":"2015","journal-title":"Br J Surg"},{"key":"10.1016\/j.jhep.2016.09.012_b0290","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.surg.2015.09.002","article-title":"Severity of cirrhosis should determine the operative modality for patients with early hepatocellular carcinoma and compensated liver function","volume":"159","author":"Huang","year":"2016","journal-title":"Surgery"},{"key":"10.1016\/j.jhep.2016.09.012_b0295","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archsurg.2008.522","article-title":"Indication of the extent of hepatectomy for hepatocellular carcinoma on cirrhosis by a simple algorithm based on preoperative variables","volume":"144","author":"Cescon","year":"2009","journal-title":"Arch Surg"},{"key":"10.1016\/j.jhep.2016.09.012_b0300","article-title":"Completion of a liver surgery complexity score and classification based on an international survey of experts","author":"Lee","year":"2016","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jhep.2016.09.012_b0305","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/SLA.0b013e3181b977a5","article-title":"Is portal hypertension a contraindication to hepatic resection?","volume":"250","author":"Cucchetti","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhep.2016.09.012_b0310","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jhep.2015.08.025","article-title":"Hepatic venous pressure gradient in the preoperative assessment of patients with resectable hepatocellular carcinoma","volume":"64","author":"Cucchetti","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.09.012_b0315","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jhep.2014.10.037","article-title":"Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study","volume":"62","author":"Vitale","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.09.012_b0320","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2016.1121","article-title":"Hierarchic interaction of factors associated with liver decompensation after resection for hepatocellular carcinoma","author":"Citterio","year":"2016","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jhep.2016.09.012_b0325","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/jhbp.215","article-title":"Can we expand the indications for laparoscopic liver resection? A systematic review and meta-analysis of laparoscopic liver resection for patients with hepatocellular carcinoma and chronic liver disease","volume":"22","author":"Morise","year":"2015","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.jhep.2016.09.012_b0330","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1089\/lap.2016.0134","article-title":"Mini-Invasive approach contributes to expand the indication for liver resection for hepatocellular carcinoma without increasing the incidence of posthepatectomy liver failure and other perioperative complications: a single-center analysis","volume":"26","author":"Gruttadauria","year":"2016","journal-title":"J Laparoendosc Adv Surg Tech A"},{"key":"10.1016\/j.jhep.2016.09.012_b0335","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1007\/s00464-015-4295-6","article-title":"Minimally invasive surgery versus percutaneous radio frequency ablation for the treatment of single small (\u2a7d3cm) hepatocellular carcinoma: a case-control study","volume":"30","author":"Vitali","year":"2016","journal-title":"Surg Endosc"},{"key":"10.1016\/j.jhep.2016.09.012_b0340","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jvir.2016.01.136","article-title":"Microwave versus radiofrequency ablation treatment for hepatocellular carcinoma: a comparison of efficacy at a single center","volume":"27","author":"Potretzke","year":"2016","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jhep.2016.09.012_b0345","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/hep.21933","article-title":"Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?","volume":"47","author":"Livraghi","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.09.012_b0350","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/hep.23181","article-title":"Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis","volume":"50","author":"N\u2019Kontchou","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.09.012_b0355","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ctrv.2010.07.006","article-title":"Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization","volume":"37","author":"Raoul","year":"2011","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jhep.2016.09.012_b0360","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/hep.21164","article-title":"Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations","volume":"43","author":"Teratani","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.09.012_b0365","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.3748\/wjg.v20.i14.4059","article-title":"Single hepatocellular carcinoma \u2a7d3cm in left lateral segment: liver resection or radiofrequency ablation?","volume":"20","author":"Kim","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2016.09.012_b0370","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/hepr.12592","article-title":"Outcomes of laparoscopic hepatic resection versus percutaneous radiofrequency ablation for hepatocellular carcinoma located at the liver surface: A case-control study with propensity score matching","volume":"46","author":"Ito","year":"2016","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhep.2016.09.012_b0375","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057249","article-title":"Laparoscopic ablation of hepatocellular carcinoma in cirrhotic patients unsuitable for liver resection or percutaneous treatment: a cohort study","volume":"8","author":"Cillo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2016.09.012_b0380","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s00464-015-4468-3","article-title":"Long-term outcome of laparoscopic ablation therapies for unresectable hepatocellular carcinoma: a single European center experience of 426 patients","volume":"30","author":"Santambrogio","year":"2016","journal-title":"Surg Endosc"},{"key":"10.1016\/j.jhep.2016.09.012_b0385","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/hpb.12264","article-title":"Laparoscopic microwave ablation in patients with hepatocellular carcinoma: a prospective cohort study","volume":"16","author":"Cillo","year":"2014","journal-title":"HPB"},{"key":"10.1016\/j.jhep.2016.09.012_b0390","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jhep.2012.11.009","article-title":"Comparison of resection and ablation for hepatocellular carcinoma: a cohort study based on a Japanese nationwide survey","volume":"58","author":"Hasegawa","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.09.012_b0395","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jhep.2015.07.013","article-title":"Prognostic impact of surgery and radiofrequency ablation on single nodular HCC <5cm: Cohort study based on serum HCC markers","volume":"63","author":"Ueno","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.09.012_b0400","doi-asserted-by":"crossref","DOI":"10.1111\/liv.13166","article-title":"Resection versus ablation for alpha-fetoprotein positive hepatocellular carcinoma within the Milan criteria: a propensity score analysis","author":"He","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2016.09.012_b0405","first-page":"3489","article-title":"Laparoscopic liver resection is a feasible treatment for patients with hepatocellular carcinoma and portal hypertension","volume":"36","author":"Harada","year":"2016","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jhep.2016.09.012_b0410","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jhep.2015.10.015","article-title":"Complete removal of the tumor-bearing portal territory decreases local tumor recurrence and improves disease-specific survival of patients with hepatocellular carcinoma","volume":"64","author":"Shindoh","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.09.012_b0415","unstructured":"Good ReseArch for Comparative Effectiveness (GRACE) principles [Available from: www.graceprinciples.org, accessed on 13\/07\/2016]."},{"key":"10.1016\/j.jhep.2016.09.012_b0420","first-page":"301","article-title":"The GRACE checklist for rating the quality of observational studies of comparative effectiveness: a tale of hope and caution","volume":"20","author":"Dreyer","year":"2014","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.jhep.2016.09.012_b0425","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.312.7023.71","article-title":"Evidence based medicine: what it is and what it isn\u2019t","volume":"312","author":"Sackett","year":"1996","journal-title":"BMJ"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827816305396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827816305396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T20:20:25Z","timestamp":1568406025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827816305396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":85,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0168827816305396"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2016.09.012","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Personalized treatment of patients with very early hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2016.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}